Impact of the COVID‐19 pandemic on pediatric oncology providers globally: A mixed‐methods study
Elizabeth Sniderman(St. Jude Children's Research Hospital), Daniel C. Moreira(St. Jude Children's Research Hospital), Rashmi Dalvi(Bombay Hospital), Yuvanesh Vedaraju(St. Jude Children's Research Hospital), Asya Agulnik(St. Jude Children's Research Hospital), Guillermo Chantada, Kathy Pritchard‐Jones(Institute of Cancer Research), Laila Hessissen(Mohammed V University), Carlos Rodríguez‐Galindo(St. Jude Children's Research Hospital), Radhikesh Ranadive(St. Jude Children's Research Hospital), Meenakshi Devidas(National Institutes of Health), Yi-Chen Chen(St. Jude Children's Research Hospital), Dylan E. Graetz(St. Jude Children's Research Hospital)
Cited by 32
Related Papers
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
|Blood|2016|1.6k
Targetable Kinase-Activating Lesions in Ph-like Acute Lymphoblastic Leukemia
|New England Journal of Medicine|2014|1.4k
The genomic landscape of pediatric and young adult T-lineage acute lymphoblastic leukemia
|Nature Genetics|2017|934
PAX5-driven subtypes of B-progenitor acute lymphoblastic leukemia
|Nature Genetics|2019|616